Associated Papers
Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay.
Curry S et al.
Journal of Virological Methods, 2008
Select a paper to view details